A management, consulting and engineering firm providing services on government-backed contracts settled a False Claims Act case with the United States and a private qui tam relator following allegations that the firm made false statements and submitted inflated invoices.
News & Insights
The U.S. Supreme Court agreed to consider a pair of whistleblower-initiated False Claims Act cases accusing two pharmacy operators of billing Medicare and Medicaid programs for prescription drugs at artificially high rates while charging non-governmentally insured customers lesser prices for those same drugs.
FTC is seeking to block Microsoft Corporation's acquisition of Activision Blizzard, Inc., claiming the acquisition may lessen competition or create a monopoly in interstate trade and commerce in the relevant markets.
The U.S. District Court for the Central District of California authorized the IRS to serve a "John Doe" summons on a California-based cryptocurrency prime dealer. The IRS is seeking information about as-yet unidentified U.S. taxpayers who conducted at least $20,000 in cryptocurrency transactions with the dealer.
A jury returned a rare verdict in a "qui tam" False Claims Act matter, finding a pharmaceutical company liable for $61 million in damages arising out of purported misconduct involving the Medicaid Drug Rebate Program.